Highlights of new treatment options for IBD from recent phase II and III trials (Abtect, Gladiator, Astro, Graviti), definitions of mild IBD episode artwork

EPISODE · Dec 19, 2025 · 24 MIN

Highlights of new treatment options for IBD from recent phase II and III trials (Abtect, Gladiator, Astro, Graviti), definitions of mild IBD

from IBD Essentials · host Axel Dignaß

Silvio Danese, Milan, internationally renowned IBD expert, former ECCO president and UEG Vice president discusses recent data from UEG 2025 on Etrasimod in mild UC (gladiator) and late breaking abstract data on obefazimod in ulcerative colitis

Episode metadata supplied by the publisher feed · Published Dec 19, 2025

Embed this episode

NOW PLAYING

Highlights of new treatment options for IBD from recent phase II and III trials (Abtect, Gladiator, Astro, Graviti), definitions of mild IBD

0:00 24:26

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of IBD Essentials?

This episode is 24 minutes long.

When was this IBD Essentials episode published?

This episode was published on December 19, 2025.

Can I download this IBD Essentials episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!